UW Carbone Cancer Center receives FDA clearance to test new regenerative medicine therapy for radiotherapy-induced dry mouth

09/08/2020

The University of Wisconsin Carbone Cancer Center has the go-ahead to start clinical trials on a first-in-human cell therapy to treat a common side effect of radiation therapy.

Remembering Heidi Dvinge: scientist, colleague, mentor and friend

04/23/2020

Heidi Dvinge, PhD, assistant professor of Biomolecular Chemistry and a member of the Carbone Cancer Center, passed away on September 20, 2019. With great sorrow over the loss of a brilliant young scientist, colleague, mentor and friend, we honor h...

Stem cells could help cancer patients fight dangerous infections

01/30/2020

Scientists at the University of Wisconsin–Madison have developed a more efficient way to grow the white blood cells, which serve as front-line defenders against bacterial infections but are often depleted as a potentially deadly side effect o...

Study: Access to Medicare increases cancer detection

01/13/2020

Access to Medicare significantly impacts detection of certain cancers and life expectancy following cancer diagnosis, according to a new study from the UW School of Medicine and Public Health that was recently published online in the Journal of Po...

UW Carbone Cancer Center physicians: All cancer patients should be screened for Hepatitis C

12/31/2019

All cancer patients should be screened for exposure to the Hepatitis C virus because cancer treatment can make an active viral infection worse, according to a statement published this month in the Journal of Oncology Practice.

Biostatistics and Medical Informatics Department tapped for $11.8 million national coordinating center

10/02/2019

A University of Wisconsin-Madison professor and his team have been chosen to lead the nation’s coordinating center for the National Cancer Institute (NCI) Cancer Prevention Clinical Trials Network (CP-CTNet).

UW-Madison cancer research conference focuses on targeted radionuclide therapy

09/19/2019

University of Wisconsin-Madison is hosting a national conference on targeted radionuclide therapy (TRT), a promising new technology that combines cytotoxic radioisotopes with molecularly targeted agents to produce an anti-cancer therapy capable of...

Simultaneous infection by two viruses the key to studying rare lymphoma

07/29/2019

New research has found that a rare blood cancer can be simulated in the lab only by simultaneously infecting white blood cells with two viruses typically found in the tumors.

Researchers probe cell division defects to gain insight into cancer

07/08/2019

From bugs to plants to animals, for all living things to grow they must create more cells.

Study: risk-based breast cancer screenings lack predictive value

06/17/2019

Starting breast-cancer screenings based on personal risk factors instead of age in women 40-49 years of age may significantly delay the detection of some early-stage breast cancers while also decreasing the number of false-positive mammograms and ...

UW study provides potential treatment strategy for aggressive lymphoma

06/12/2019

A research team at the University of Wisconsin Carbone Cancer Center has found a new tumor-causing mechanism that contributes to the development of the most common form of non-Hodgkin lymphoma.

Darcie Moore, Zachary Morris receive 2019 Shaw Scientist Awards

06/04/2019

University of Wisconsin School of Medicine and Public Health assistant professor of neuroscience Darcie Moore, PhD, and assistant professor of human oncology Zachary Morris, MD, PhD, are recipients of 2019 Shaw Scientist Awards from the Greater Mi...

Carbone Cancer Center members take new leadership roles

04/09/2019

Four members of the University of Wisconsin Carbone Cancer Center have been named to new leadership roles.

Personalized in vitro model enables drug screening for kidney cancer

03/25/2019

One way to treat the most common type of kidney cancer is to use anti-angiogenic drugs to cut off the blood supply to the tumors, but patients respond differently to the drugs, and choosing the wrong one can make the cancer grow faster.

The Ride funds $365,000 in research at Carbone Cancer Center

02/11/2019

On a beautiful September Sunday, hundreds of bicyclists pedaled the roads of eastern Dane County on The Ride to raise money for cancer research.

First Carbone Cancer Center patient receives experimental therapy to prevent infections during chemotherapy

12/20/2018

Michael Toelle, superintendent of the Tomorrow River Schools, recently became the first patient at the University of Wisconsin Carbone Cancer Center to be infused with an experimental cellular therapy designed to prevent infections in leukemia pat...

Wisconsin researchers well-represented at international radiation oncology conference

12/12/2018

The 60th annual meeting of the American Society for Radiation Oncology (ASTRO), the world’s premier radiation oncology society, got underway this week in San Antonio, Texas, with a strong Wisconsin presence.

UW Carbone blood researchers to present at hematology conference

11/30/2018

When dozens of University of Wisconsin blood researchers escape to sunny San Diego this weekend, they will not just be there for the weather – they are attending the American Society for Hematology’s (ASH) Annual Conference.

Breast cancer expert Kari Wisinski joins Big Ten research leadership

11/20/2018

Kari Wisinski, MD, a breast cancer specialist with the University of Wisconsin Carbone Cancer Center, has been named to the steering committee of the Big Ten Cancer Research Consortium.

Mutations in key blood cell protein disrupt development, predispose to leukemia

11/12/2018

When a key gene in blood cell development, GATA-2, is mutated, it causes a predisposition to the development of acute myeloid leukemia (AML), and the changes in GATA-2 were believed to diminish its protein function. 

Sean Ronnekleiv-Kelly earns 2018 Carbone Young Investigator Award

11/05/2018

Sean Ronnekleiv-Kelly, MD, a surgical oncologist with the UW Carbone Cancer Center and Department of Surgery, has been awarded the 2018 Paul P. Carbone Young Investigator Award to study causes of and treatments for pancreatic cancer. He joine...

Upcoming event focuses on men's health

10/31/2018

Getting men to talk about their health at all takes some doing, so Second Baptist Church is hosting a Madison event targeted at men’s health awareness. As a collaborative effort with the Cancer Health Disparities Initiative of the UW Carbone...

Evie Carchman awarded grant to study anal cancer

07/25/2018

While people infected with HIV are living longer due to better therapies, their weakened immune systems are linked to what is now a leading cause of death in the HIV population: cancer.

Cai group recognized for research achievements at annual imaging meeting

07/10/2018

The Molecular Imaging and Nanotechnology Laboratory had another successful year at June's Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting in Philadelphia.

Forgotten molecules find new purpose at Carbone Cancer Center

07/10/2018

On a rainy day last fall, chemist Scott Wildman left his office on the UW–Madison campus and drove to a retirement community on the city’s west side to bring 40 years of scientific work out of the dark.

UW Carbone study to look for ways to personalize therapy in colorectal cancer

06/15/2018

A five-year, $3 million grant from the National Cancer Institute will support UW Carbone Cancer Center physician-researcher Dusty Deming, MD, and colleagues in their pursuit of more effective treatments for colorectal-cancer patients.

UW-Madison researchers discover effective way to generate powerful blood cells for immunotherapy

05/25/2018

Scientists at the University of Wisconsin School of Medicine and Public Health have found a potentially improved method for creating T cells to treat cancer and infections.

Study seeks 'extreme survivors' of metastatic breast cancer

05/08/2018

Some patients can live for years, and even decades, after breast cancer has spread to their bones and other tissues.

UW Carbone scientists to present at annual cancer research conference

04/16/2018

As cancer researchers from across the country descend on Chicago this week for the American Association of Cancer Research’s annual conference, University of Wisconsin Carbone Cancer Center faculty, staff and students are among them.

Fewer mammography recalls associated with higher rates of breast cancers found between screenings

04/03/2018

Calling fewer women back for more testing after a suspicious mammography finding is associated with higher rates of breast cancers found between screenings.

UW Carbone Cancer Center receives 'outstanding' grade on renewal

02/14/2018

Every five years, the UW Carbone Cancer Center receives a thorough check-up from the nation’s top cancer researchers. Leaders recently learned that it passed its review with flying colors and will retain its designation as Wisconsin’s ...

Dense breasts, inflammation linked to cancer risk

02/13/2018

A new study by University of Wiscconsin Carbone Cancer Center researchers has found that dense breasts and inflammation are associated with poor prognosis in breast-cancer patients, and suggests that an FDA-approved drug may improve prognosis for ...

The Ride funds $352,000 in cancer research at Carbone Cancer Center

01/25/2018

Research efforts at the University of Wisconsin Carbone Cancer Center received a $352,000 boost this weekend when The Ride announced the winners of 14 scholarships during the Badger hockey game Saturday night.

Study provides a potential therapeutic strategy for aggressive lymphoma

01/11/2018

Researchers at the University of Wisconsin School of Medicine and Public Health have found a molecular regulator that controls cell life in diffuse large B cell lymphoma, the most common, aggressive form of lymphoma.

New study to help women make better breast-cancer surgery decisions

12/21/2017

Women face big decisions soon after being hit with a cancer diagnosis, including whether to have a breast-conserving lumpectomy or mastectomy.

Myeloma vaccine research earns $600,000 Leukemia and Lymphoma Society grant

12/07/2017

UW Carbone Cancer Center hematologist and myeloma researcher Fotis Asimakopoulos, MD, PhD, was awarded a Leukemia and Lymphoma Society grant to identify patients mostly likely to benefit from a personalized cancer vaccine.

Jim Cleary Named a Visionary in Hospice and Palliative Medicine

12/06/2017

Jim Cleary, MD, founding medical director of the Palliative Medicine Service at UW Health, was named one of the 30 most influential leaders in hospice and palliative medicine, the medical specialty focused on relieving suffering and improving qual...

UW study uses bio-panning to find human antibodies for brain cancer stem cells

11/27/2017

Using a method described as similar to panning for gold, Carbone Cancer Center scientists discovered human antibodies for the cancer stem cells of glioblastoma, one of the most difficult brain cancers to treat.

UW Carbone oncologist leads effort to educate about cancer risk of alcohol

11/08/2017

Drinking alcohol increases the risk of several types of cancer, something many of Dr. Noelle LoConte's patients are surprised to learn.

Carbone Cancer Center members recognized as Vilas Professors

07/12/2017

Three UW Carbone Cancer Center members recently earned Vilas Professorships.